//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Update from @ascocancer.bsky.social #ASCO26: Pumitamig + chemotherapy delivered promising early activity in first-line advanced #NSCLC across histologies and PD-L1 expression levels. #lcsm Read more: www.onclive.com/view/pumitam...
4h
Pumitamig plus chemotherapy generated strong responses across NSCLC subtypes and PD-L1 levels with manageable safety in ROSETTA Lung-02.
Pumitamig Plus Chemo Demonstrates Encouraging Efficacy in Frontline NSCLC | OncLive
www.onclive.com
OncLive